Clinical Profile, Prognostic Factors, and Outcome Prediction in Hospitalized Patients With Bloodstream Infection: Results From a 10-Year Prospective Multicenter Study

Abstract

Background: Bloodstream infection (BSI) is one of the most common serious bacterial infections worldwide and also a major contributor to in-hospital mortality. Determining the predictors of mortality is crucial for prevention and improving clinical prognosis in patients with nosocomial BSI.Methods: A nationwide prospective cohort study was conducted from 2007 until 2016 in 16 teaching hospitals across China. Microbiological results, clinical information, and patient outcomes were collected to investigate the pathogenic spectrum and mortality rate in patients with BSI and identify outcome predictors using multivariate regression, prediction model, and Kaplan–Meier analysis.Results: No significant change was observed in the causative pathogen distribution during the 10-year period and the overall in-hospital mortality was 12.83% (480/3,741). An increased trend was found in the mortality of patients infected with Pseudomonas aeruginosa or Acinetobacter baumannii, while a decreased mortality rate was noted in Staphylococcus aureus-related BSI. In multivariable-adjusted models, higher mortality rate was significantly associated with older age, cancer, sepsis diagnosis, ICU admission, and prolonged hospital stay prior to BSI onset, which were also determined using machine learning-based predictive model achieved by random forest algorithm with a satisfactory performance in outcome prediction.Conclusions: Our study described the clinical and microbiological characteristics and mortality predictive factors in patients with BSI. These informative predictors would inform clinical practice to adopt effective therapeutic strategies to improve patient outcomes.

Polymyxin B Combined with Minocycline: A Potentially Effective Combination against blaOXA-23-harboring CRAB in In Vitro PK/PD Model

“…Bloodstream infections are most common (37/131 studies, 28%) severe infections among reported studies, and Acinetobacter baumannii is the top pathogen (52/131 studies, 38.5% and 4395/11,546 patients, 38%) [ 1 ]. The mortality of Acinetobacter baumannii -related bloodstream infections showed an increasing trend in a 10-year prospective study in China [ 2 ]. There is an urgent need for rational and effective medication schemes to be developed in clinics.…”

In Vitro Activity of KBP-7072 against 536 Acinetobacter baumannii Complex Isolates Collected in China

“…Owing to the characteristics of multidrug-resistance or extensively drug-resistance, the infections caused by A. baumannii isolates were usually associated with high mortality, particularly in the bloodstream and central nervous system infections ( 9 ). An increasing trend was observed in the mortality of patients infected with A. baumannii from a 10-year prospective multicenter study in hospitalized patients with bloodstream infection ( 13 ).…”

A 12-year retrospective single-center comparison of pneumonia- and non-pneumonia-related Acinetobacter baumannii complex bacteremia

“…A nationwide prospective cohort study conducted from 2007 to 2016 in 16 teaching hospitals across China suggested that A. baumannii was one of the top four pathogens responsible for bacteremia, accounting for approximately 7.03% of bloodstream bacterial isolates [21] . Data from the China Antimicrobial Surveillance Network (CHINET) revealed signi cant increases in the rates of resistance to carbapenem antibiotics, which ranged from 31% in 2005 to 79.2% in 2018 [22] .…”